Recent developments in biological activities of indanones.

Eur J Med Chem

Pharmaceutical Sciences Department, College of Pharmacy, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, IL 60064, USA. Electronic address:

Published: September 2017

Indanone is one of the privileged structures in medicinal chemistry and it's commonly associated with various pharmacologically active compounds. The indanone moiety is found in several natural compounds and also, it can be used as intermediate in the synthesis of many different types of medicinally important molecules. Among the medicinally important indanones, the most significant drug probably is donepezil (IV), an acetylcholinesterase (AChE) inhibitor, which has been approved by the US Food and Drug Administration for the treatment of Alzheimer's disease (AD). Along with donepezil, the indanone moiety can be seen in a number of other pre-clinical and clinical candidates which belong to different categories with diverse therapeutic activities. In summary, the present review article encompasses the recent biological applications such as antialzheimer, anticancer, antimicrobial and antiviral activity of various indanone derivatives.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2017.06.032DOI Listing

Publication Analysis

Top Keywords

indanone moiety
8
developments biological
4
biological activities
4
activities indanones
4
indanone
4
indanones indanone
4
indanone privileged
4
privileged structures
4
structures medicinal
4
medicinal chemistry
4

Similar Publications

Rasagiline (RAS) is a medication for Parkinson's disease that increases dopamine levels in the brain by inhibiting monoamine oxidase, helping to alleviate symptoms. The proposed study aims to develop an efficient, feasible, and sensitive method for RAS assay, utilizing Pyrosin B dye, a convenient fluorescent ligand. Combining the RAS analyte with Pyrosin B ligand in a mildly acidic buffered solution rapidly quenches the native fluorescence of the ligand.

View Article and Find Full Text PDF

Indanone: a promising scaffold for new drug discovery against neurodegenerative disorders.

Drug Discov Today

August 2024

University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh 160014, India.

Indanone is a versatile scaffold that has a number of pharmacological properties. The successful development and ensuing approval of indanone-derived donepezil as a drug of choice for Alzheimer's disease attracted significant scientific interest in this moiety. Indanones could act as small molecule chemical probes as they have strong affinity towards several critical enzymes associated with the pathophysiology of various neurological disorders.

View Article and Find Full Text PDF

Mirabegron (MRB) is a β-adrenoceptor agonist used for managing overactive bladder syndrome. A cost-effective, environmentally friendly, and highly sensitive spectrofluorimetric method was suggested to serve the purpose of quantifying MRB in its pure state, pharmaceutical tablets, spiked human plasma and urine, and testing content uniformity. In the present study, ninhydrin and phenylacetaldehyde react with the amino group moiety of MRB in Teorell-Stenhagen buffer (pH 7.

View Article and Find Full Text PDF

Most of the known rearrangement reactions of donor-acceptor cyclopropanes (DACs) involve the migration of cationic carbon atom to anionic carbon or heteroatoms in 1,3- or 1,4-positions. In the present work, we observed that spiro DACs based on 1,3-indanedione or 1-indanone moiety undergo intramolecular 1,2-aroyl migration when treated with titanium(IV) chloride to afford 1,4-naphthoquinones and α-naphthols readily. The reactions take place through the formation of putative 1,3-dipolar intermediates, followed by cleavage and migration of the aroyl group to the adjacent carbon to afford the ring-expansion products.

View Article and Find Full Text PDF
Article Synopsis
  • A series of new compounds combining tacrine and donepezil were created to target Alzheimer's disease by inhibiting specific enzymes related to neurotransmission.
  • The synthesized hybrids showed effective inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), indicating their potential as multifunctional treatments for AD.
  • The compounds not only protected nerve cells from damage but also demonstrated good brain permeability and low toxicity in human cell lines, making them promising candidates for further development.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!